Harvest Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2M | Sell |
16,480
-1,186
| -7% | -$1.2M | 0.64% | 34 |
|
|
2025
Q4 | $19M | Buy |
17,666
+10,131
| +134% | +$9.69M | 0.71% | 23 |
|
|
2025
Q3 | $5.74M | Sell |
7,535
-4,467
| -37% | -$3.32M | 0.24% | 79 |
|
|
2025
Q2 | $9.35M | Sell |
12,002
-8,686
| -42% | -$6.75M | 0.44% | 44 |
|
|
2025
Q1 | $17.1M | Buy |
20,688
+1,479
| +8% | +$1.23M | 0.85% | 18 |
|
|
2024
Q4 | $14.8M | Sell |
19,209
-1,314
| -6% | -$1.09M | 0.69% | 24 |
|
|
2024
Q3 | $18.2M | Buy |
20,523
+2,995
| +17% | +$2.69M | 1.08% | 18 |
|
|
2024
Q2 | $15.9M | Buy |
17,528
+4,978
| +40% | +$3.98M | 1.15% | 20 |
|
|
2024
Q1 | $9.74M | Buy |
12,550
+3,346
| +36% | +$2.38M | 0.87% | 20 |
|
|
2023
Q4 | $5.37M | Buy |
9,204
+355
| +4% | +$207K | 0.84% | 22 |
|
|
2023
Q3 | $4.75M | Buy |
8,849
+1,060
| +14% | +$546K | 0.83% | 21 |
|
|
2023
Q2 | $3.65M | Buy |
7,789
+1,062
| +16% | +$445K | 0.73% | 25 |
|
|
2023
Q1 | $2.31M | Sell |
6,727
-1,437
| -18% | -$485K | 0.51% | 35 |
|
|
2022
Q4 | $2.99M | Buy |
8,164
+796
| +11% | +$282K | 0.77% | 26 |
|
|
2022
Q3 | $2.38M | Buy |
7,368
+585
| +9% | +$185K | 0.69% | 30 |
|
|
2022
Q2 | $2.2M | Buy |
6,783
+1,077
| +19% | +$323K | 0.61% | 32 |
|
|
2022
Q1 | $1.63M | Sell |
5,706
-2,161
| -27% | -$556K | 0.34% | 34 |
|
|
2021
Q4 | $2.18M | Buy |
7,867
+833
| +12% | +$211K | 0.37% | 36 |
|
|
2021
Q3 | $1.62M | Buy |
7,034
+1,573
| +29% | +$388K | 0.37% | 31 |
|
|
2021
Q2 | $1.26M | Buy |
5,461
+435
| +9% | +$87.4K | 0.13% | 44 |
|
|
2021
Q1 | $938K | Buy |
5,026
+1,961
| +64% | +$384K | 0.09% | 53 |
|
|
2020
Q4 | $517K | Sell |
3,065
-2,355
| -43% | -$352K | 0.04% | 75 |
|
|
2020
Q3 | $794K | Sell |
5,420
-425
| -7% | -$65.8K | 0.07% | 60 |
|
|
2020
Q2 | $954K | Buy |
5,845
+100
| +2% | +$15.3K | 0.09% | 42 |
|
|
2020
Q1 | $795K | Buy |
5,745
+2,786
| +94% | +$383K | 0.09% | 41 |
|
|
2019
Q4 | $548K | Sell |
2,959
-49
| -2% | -$5.68K | 0.06% | 52 |
|
|
2019
Q3 | $336K | Buy |
3,008
+661
| +28% | +$73.6K | 0.04% | 77 |
|
|
2019
Q2 | $260K | Sell |
2,347
-2,765
| -54% | -$326K | 0.03% | 92 |
|
|
2019
Q1 | $663K | Sell |
5,112
-830
| -14% | -$101K | 0.11% | 42 |
|
|
2018
Q4 | $688K | Sell |
5,942
-848
| -12% | -$94.7K | 0.14% | 40 |
|
|
2018
Q3 | $729K | Buy |
+6,790
| New | +$679K | 0.13% | 44 |
|
Other funds holding LLY
VCM
VPM
Harvest Fund Management's LLY Position: Q1 2026 in Review
Harvest Fund Management reduced its Eli Lilly (LLY) stake by 6.7% in Q1 2026, selling an estimated $1.2M and leaving 16,480 shares worth $15.2M. The position accounts for 0.64% of the portfolio, ranked #34.
Harvest Fund Management first reported a position in LLY in Q3 2018 and has held it in 31 quarters since. The position peaked at $19M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Harvest Fund Management held 16,480 shares of Eli Lilly worth $15.2M as of Q1 2026.
- Harvest Fund Management sold 1,186 Eli Lilly shares in Q1 2026, an estimated $1.2M.
- Eli Lilly made up 0.64% of Harvest Fund Management's portfolio in Q1 2026, its #34 holding.
- Harvest Fund Management first reported a position in Eli Lilly in Q3 2018 and has held it in 31 quarters since.
- Harvest Fund Management's Eli Lilly position peaked at $19M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.